Lifeward Ltd. and MYOLYN, Inc. announced on March 5, 2025, an expanded exclusive contract to increase patient access to the MyoCycle FES Cycling Therapy System for home use through the Lifeward organization. This agreement builds upon their existing distribution partnership.
Under the new contract, Lifeward will manage referrals and sales of the MyoCycle Home product for patients transitioning from clinical to home use. This leverages Lifeward's existing case management infrastructure, which is also used for the ReWalk Exoskeleton.
MYOLYN will continue to directly service patients already discharged from therapy who seek a home FES cycling program. This expanded partnership aims to better serve patients who have completed clinic therapy and wish to continue rehabilitation at home, enhancing Lifeward's ability to reach a broader patient population.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.